• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diffuse midline (H3 K27M-mutant) glioma in adults-When resection fails to matter.

作者信息

Zhang Ying, Hudson Kadie, Abounader Roger

机构信息

Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.

Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.

出版信息

Neuro Oncol. 2024 Aug 5;26(8):1494-1495. doi: 10.1093/neuonc/noae099.

DOI:10.1093/neuonc/noae099
PMID:38829317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11300008/
Abstract
摘要

相似文献

1
Diffuse midline (H3 K27M-mutant) glioma in adults-When resection fails to matter.成人弥漫性中线（H3 K27M突变型）胶质瘤——手术切除无效时。
Neuro Oncol. 2024 Aug 5;26(8):1494-1495. doi: 10.1093/neuonc/noae099.
2
Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort study.关西中枢神经系统肿瘤分子诊断网络（关西网络）中伴有H3F3A基因突变的弥漫性非中线胶质瘤的特征与预后：多中心回顾性队列研究
Acta Neuropathol Commun. 2025 Apr 16;13(1):77. doi: 10.1186/s40478-025-01989-y.
3
An adult case of diffuse midline glioma with H3 K27M mutation.弥漫性中线胶质瘤伴 H3 K27M 突变的 1 例成人病例。
Neuropathology. 2020 Dec;40(6):627-631. doi: 10.1111/neup.12689. Epub 2020 Sep 20.
4
Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.影像学诊断的中线胶质瘤中 H3 K27M 突变的发生率及临床病理特征。
J Neurooncol. 2019 May;143(1):87-93. doi: 10.1007/s11060-019-03134-x. Epub 2019 Mar 12.
5
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.弥漫性中线胶质瘤，H3 K27M 突变的转录组和表观遗传分析根据突变的组蛋白 H3 的类型而不是幕上或幕下位置对两个亚组进行区分。
Acta Neuropathol Commun. 2018 Nov 5;6(1):117. doi: 10.1186/s40478-018-0614-1.
6
Slow-Growing Thalamic Glioma with Histone H3 Lysine 27-to-Methionine Mutation: 3-Year Follow-Up Before Surgical Intervention.生长缓慢的丘脑胶质瘤伴有组蛋白 H3 赖氨酸 27 至蛋氨酸突变：手术干预前的 3 年随访。
World Neurosurg. 2019 Jul;127:266-268. doi: 10.1016/j.wneu.2019.04.054. Epub 2019 Apr 11.
7
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.接受选择性 DRD2 拮抗剂 ONC201 治疗的小儿和成人 H3 K27M 突变型弥漫中线脑胶质瘤。
J Neurooncol. 2019 Oct;145(1):97-105. doi: 10.1007/s11060-019-03271-3. Epub 2019 Aug 27.
8
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.弥漫性高级别胶质瘤伴 H3 K27M 突变无论肿瘤位置如何，预后均较差。
Neuro Oncol. 2018 Jan 10;20(1):123-131. doi: 10.1093/neuonc/nox149.
9
High frequency of H3 K27M mutations in adult midline gliomas.H3 K27M 突变在成人中线胶质瘤中的高频发生。
J Cancer Res Clin Oncol. 2019 Apr;145(4):839-850. doi: 10.1007/s00432-018-02836-5. Epub 2019 Jan 4.
10
Characteristics of H3 K27M-mutant gliomas in adults.成人 H3 K27M 突变型神经胶质瘤的特征。
Neuro Oncol. 2017 Aug 1;19(8):1127-1134. doi: 10.1093/neuonc/now274.

本文引用的文献

1
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection's limited influence on overall survival, ATRX as molecular prognosticator.多中心研究成人 H3 K27M 突变型脑胶质瘤的启示：手术切除对总生存期的影响有限， ATRX 作为分子预后标志物。
Neuro Oncol. 2024 Aug 5;26(8):1479-1493. doi: 10.1093/neuonc/noae061.
2
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions.H3 K27M 改变的胶质瘤和弥漫性内生性脑桥胶质瘤：治疗现状与未来方向的半系统综述
Neuro Oncol. 2024 May 3;26(Supplement_2):S110-S124. doi: 10.1093/neuonc/noad220.
3
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.新诊断的无对比增强（低级别外观）脑胶母细胞瘤的手术治疗和结果： RANO 切除组报告。
Neuro Oncol. 2024 Jan 5;26(1):166-177. doi: 10.1093/neuonc/noad160.
4
A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma.用于 H3 K27M 突变型弥漫性中线胶质瘤患者的验证预后列线图。
Sci Rep. 2023 Jun 20;13(1):9970. doi: 10.1038/s41598-023-37078-0.
5
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.使用新的 RANO 切除范围分类对复发性胶质母细胞瘤再次切除的预后评估：来自 RANO 切除组的报告。
Neuro Oncol. 2023 Sep 5;25(9):1672-1685. doi: 10.1093/neuonc/noad074.
6
Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas: A Systematic Review and Meta-analysis.儿童高级别胶质瘤患者的肿瘤切除范围与生存：系统评价和荟萃分析。
JAMA Netw Open. 2022 Aug 1;5(8):e2226551. doi: 10.1001/jamanetworkopen.2022.26551.
7
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.新胶质母细胞瘤切除范围分类系统的预后验证： RANO 切除组报告。
Neuro Oncol. 2023 May 4;25(5):940-954. doi: 10.1093/neuonc/noac193.
8
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类：概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
9
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.弥漫性高级别胶质瘤伴 H3 K27M 突变无论肿瘤位置如何，预后均较差。
Neuro Oncol. 2018 Jan 10;20(1):123-131. doi: 10.1093/neuonc/nox149.
10
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.预测新诊断胶质母细胞瘤患者生存的列线图：欧洲癌症研究与治疗组织（EORTC）和加拿大国家癌症研究所（NCIC）试验26981-22981/CE.3的预后因素分析
Lancet Oncol. 2008 Jan;9(1):29-38. doi: 10.1016/S1470-2045(07)70384-4. Epub 2007 Dec 21.